Despite the potential regulatory role of MAT2A translocation in tumor development, whether MAT2A distribution affect in breast cancer progression is unknown, thus we aimed to explore the relationship between MAT2A distribution and breast cancer clinical indicators. The gene discussed is MAT2A; the disease is neoplasm.